scholarly journals Risk of Fatal Adverse Events after H1N1 Influenza Vaccination

2010 ◽  
Vol 50 (11) ◽  
pp. 1548-1549 ◽  
Author(s):  
Haruka Nakada ◽  
Hiroto Narimatsu ◽  
Masaharu Tsubokura ◽  
Naoko Murashige ◽  
Tomoko Matsumura ◽  
...  
Keyword(s):  
Adverse Events ◽  
Influenza Vaccination ◽  
H1n1 Influenza ◽  
Fatal Adverse Events

scholarly journals Risk of Fatal Adverse Events after H1N1 Influenza Vaccine: Limitations of Passive Surveillance Data

2010 ◽  
Vol 51 (7) ◽  
pp. 871-872 ◽  
Author(s):  
Michael M. McNeil ◽  
Karen R. Broder ◽  
Claudia Vellozzi ◽  
Frank DeStefano
Keyword(s):  
Adverse Events ◽  
Influenza Vaccine ◽  
H1n1 Influenza ◽  
Surveillance Data ◽  
Passive Surveillance ◽  
Fatal Adverse Events

Adverse events associated with the 2009 H1N1 influenza vaccination and the vaccination coverage rate in health care workers

2011 ◽  
Vol 39 (1) ◽  
pp. 69-71 ◽  
Author(s):  
Sang-Won Park ◽  
Ju-Hyung Lee ◽  
Eu Suk Kim ◽  
Yee Gyung Kwak ◽  
Chi-Sook Moon ◽  
...  
Keyword(s):  
Health Care ◽  
Adverse Events ◽  
Influenza Vaccination ◽  
Vaccination Coverage ◽  
Health Care Workers ◽  
H1n1 Influenza ◽  
Coverage Rate ◽  
Vaccination Coverage Rate ◽  
Care Workers ◽  
2009 H1n1

Clinical pearls for H1N1 influenza vaccination

2010 ◽  
Vol 125 (4) ◽  
pp. 951-952 ◽  
Author(s):  
Gregory V. Marcotte
Keyword(s):  
Influenza Vaccination ◽  
H1n1 Influenza

scholarly journals Predictors of adverse prognosis in patients with infective endocarditis in a surgical referral center

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
V Scheggi ◽  
I Olivotto ◽  
N Ceschia ◽  
I Merilli ◽  
V Andrei ◽  
...  
Keyword(s):  
Renal Failure ◽  
Infective Endocarditis ◽  
Adverse Events ◽  
Ejection Fraction ◽  
Relapse Rate ◽  
Left Ventricular Ejection ◽  
All Cause Mortality ◽  
Fatal Adverse Events

Abstract Background Despite optimal medical and surgical treatment, mortality in infective endocarditis (IE) remains high. Aim of this study was to identify predictors of long term mortality for any cause, adverse event rate, relapse rate and valvular dysfunction at follow-up, in a high-volume surgical center. Methods We retrospectively analyzed 358 consecutive patients (127 women) admitted to our department with definite diagnosis of IE not device-related. IE occurred on native valves in 224 patients (63%); the infection involved the aortic valve in 192 (54%), mitral valve in 139 (39%) and tricuspid valve in 26 (7%). Overall 285 (80%) patients underwent surgery and 73 (20%) were treated conservatively, 38 due to absence of surgical indication and 35 due to refusal or prohibitive surgical risk. Long-term follow-up was obtained by structured telephone interviews. Primary endpoints were all-cause mortality, freedom from recurrent endocarditis, postoperative incidence of major adverse events (hospitalization for any cause, pace-maker implantation, new onset of atrial fibrillation, sternal dehiscence), worsening of left ventricular ejection fraction (LVEF) and valvular dysfunction. Results Mean age was 65 years (SD 15.2). Mean vegetation length was 8.9 mm (SD 7.6). Endocarditis was left-sided in 332 (93%). Average follow-up was 6 months. At univariable analysis, mortality was associated with female gender (p=0.031), age (p<0.001), higher EuroSCORE 2 (p<0.001), chronic renal failure (p<0.001), diabetes (p=0.002), brain embolism on presentation (p=0.05), double valve infection (p=0.008), low ejection fraction (p<0.001), paravalvular extension (p=0.031), prosthetic infection (p=0.018), exclusion from surgery if indicated (p<0.001), high procalcitonin levels (p=0.035); factors associated with a significantly lower mortality were streptococcal infection (p=0.04; OR 0.34) and early surgery (p=0.009, OR 0.55). At multivariable analysis independent predictors of all-cause mortality were lower EF, EuroSCORE2, procalcitonin levels and diabetes. Non-fatal adverse events were associated with renal failure (p 0.035, OR 2.8). Relapse rate was associated with S aureus infection (p=0.005, OR 3.8), right-sided endocarditis (p<0.001, OR 6.7) and drug abuse (p<0.001, OR 9.4). Conclusions The present study shows that low EF, EuroSCORE2, procalcitonin levels and diabetes are independent predictors of death in patients with IE. Non-fatal adverse events are more frequent in patients with renal failure. Relapse rate is higher in drug abusers. These informations may help personalize follow-up strategies after acute admission for IE. Funding Acknowledgement Type of funding source: None

Influenza vaccination in patients with lung cancer receiving anti–programmed death receptor 1 immunotherapy does not induce immune-related adverse events

2018 ◽  
Vol 104 ◽  
pp. 182-187 ◽  
Author(s):  
Dirk H. Wijn ◽  
Geert H. Groeneveld ◽  
Albert M. Vollaard ◽  
Mirte Muller ◽  
Jacco Wallinga ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Adverse Events ◽  
Influenza Vaccination ◽  
Death Receptor ◽  
Programmed Death

scholarly journals Perception of the A/H1N1 influenza pandemic and acceptance of influenza vaccination by Université Claude Bernard Lyon 1 staff: A descriptive study

2015 ◽  
Vol 11 (3) ◽  
pp. 727-731 ◽  
Author(s):  
Sélilah Amour ◽  
Khaled Djhehiche ◽  
Adeline Zamora ◽  
Alain Bergeret ◽  
Philippe Vanhems
Keyword(s):  
Influenza Vaccination ◽  
Influenza Pandemic ◽  
Descriptive Study ◽  
H1n1 Influenza ◽  
Claude Bernard ◽  
H1n1 Influenza Pandemic

scholarly journals A pilot study showing a stronger H1N1 influenza vaccination response during pregnancy in women who subsequently deliver preterm

2019 ◽  
Vol 132 ◽  
pp. 16-20 ◽  
Author(s):  
Sandra Andorf ◽  
Sanchita Bhattacharya ◽  
Brice Gaudilliere ◽  
Gary M. Shaw ◽  
David K. Stevenson ◽  
...  
Keyword(s):  
Pilot Study ◽  
Influenza Vaccination ◽  
H1n1 Influenza ◽  
Vaccination Response

Concerns about study on maternal H1N1 influenza vaccination and offspring mortality

BMJ ◽  
2016 ◽  
pp. i775
Author(s):  
Junya Makiyama ◽  
Michihiro Kono ◽  
Sayaka Shimizu
Keyword(s):  
Influenza Vaccination ◽  
H1n1 Influenza ◽  
Offspring Mortality

Risk of fatal adverse events in cancer patients treated with sunitinib

2019 ◽  
Vol 137 ◽  
pp. 115-122 ◽  
Author(s):  
Bin Zhao ◽  
Hong Zhao ◽  
Jiaxin Zhao
Keyword(s):  
Adverse Events ◽  
Cancer Patients ◽  
Fatal Adverse Events
Sign in / Sign up

Export Citation Format

Share Document